N-benzoylcytidine,
N4-Benzoylcytidine,
13089-48-0,
Cytidine, N-benzoyl-,
MFCD00010572,
bz-rc,
N-[1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide,
N-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide,
N4-Benzoylcytidine;N-(1-(3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide,
n6-benzoyl,
n4-bz-rc,
4-n-benzoyl cytidine,
n4-benzoyl-d-cytidine,
PubChem14485,
n(sup 4)benzoylcytidine,
N4-Benzoylcytidine, 99%,
KSC180K2H,
SCHEMBL565904,
CTK0I0523,
BNXBRFDWSPXODM-BPGGGUHBSA-N,
ZINC6569119,
ANW-19240,
DT1144,
MFCD01457402,
AKOS015839054,
AKOS015895282,
CM14345,
RTR-004223,
CJ-13022,
DB-041991,
ST2407345,
TR-004223,
A-8308,
J-700223,
NSC242979,
CID10066259,
N-(1-(3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide,
N4-Benzoylcytidine, 98%, a reverse transcriptase inhibitor against the HIV-1 virus - 1G 1g,